It is important to appreciate, however, that the increased risk relates to a disorder that is relatively uncommon. Given the numbers of participants who have been recruited to clinical trials and the large number of people globally who use GLP-1 RAs, we should be confident that if corroborated, the absolute risk of developing NAION in direct relation to taking semaglutide must indeed be rare, Susan Mollan, MBcHP, of University Hospitals Birmingham NHS Foundation Trust , in England, wrote in a commentary published with the study
Irimajiri K
On the other hand, the cost curve is brutal
Special populations need consideration
Eating ice cream will not stop the medication from working, but it may temporarily slow your weight loss progress if done frequently
F., McKenney, J., Bloedon, L